C17 COUNCIL REPORT | MAY 2011C17 guidelines
Guideline for Primary Antifungal Prophylaxis for Pediatric Patients with Cancer and Hematopoietic Stem Cell Transplant Recipients (Completed; Release on-hold pending journal publication)
Guideline for platelet transfusion thresholds for pediatric hematology / oncology patients (Updated March 2011) This guideline has been endorsed by the Pediatric Oncology Group of Ontario
 |
||
|
||
|
||
|
||
C17 Endorsement of Guidelines Developed by Other Organizations
International Guideline for the Management of Fever and Neutropenia in Children with Cancer and/or Undergoing Hematopoietic Stem Cell Transplantation (2012)
The complete guideline, a short version (published in the Journal of Clinical Oncology) and associated supporting materials are available at: http://www.sickkids.ca/HaematologyOncology/IPFNG/index.html
The citation for the JCO guideline publication is: Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher B, Hakim H, Santolaya M, Castagnola E, Davis BL, Dupuis LL, Gibson F, Groll AH, Gaur A, Gupta A, Kebudi R, Petrilli S, Steinbach WJ, Villarroel M, Zaoutis T, Sung L. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. Journal of Clinical Oncology (2012) 30:4427-38
The Pediatric Oncology Group of Ontario Guideline for the Prevention of Acute Nausea and Vomiting Due to Antineoplastic Medication in Pediatric Cancer Patients (2012)
The complete guideline and a summary version are available at: http://www.pogo.ca/healthcare/practiceguidelines/acuteainvguideline/
A condensed version of this guideline has been accepted for publication in Pediatric Blood and Cancer: Dupuis LL, Boodhan S, Holdsworth M, Robinson PD, Hain R, Portwine C, O’Shaughnessy E and Sung L. Guideline for the Prevention of Acute Nausea and Vomiting due to Antineoplastic Medication in Pediatric Cancer Patients. Pediatric Blood and Cancer (2013) (In press)
The Pediatric Oncology Group of Ontario (POGO) Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients (2010)
The complete guideline and a summary version are available at: http://www.pogo.ca/healthcare/practiceguidelines/pogoemetogenicitycla/
A condensed version of this guideline has been published in Pediatric Blood and Cancer: Dupuis LL, Boodhan S, Sung L, Portwine C, Hain R, McCarthy P, Holdsworth M. Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients. Pediatric Blood and Cancer (2011) 57:191-8.
|
|
||
C17 Guidelines Currently Being Developed
Guideline for Maintenance Care of Central Venous Access Devices in Pediatric Hematology / Oncology Patients (Expected release date: Fall, 2013)
Guideline for Educational Planning and School Re-entry for Pediatric Oncology Patients (Expected release date: Fall, 2013)
For further information regarding C17 Guidelines please contact us at c17.guidelines@gmail.com.
